These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30608147)

  • 41. Qualitative and quantitative analysis of 2, 5-anhydro-d-mannitol in low molecular weight heparins with high performance anion exchange chromatography hyphenated quadrupole time of flight mass spectrometry.
    Yi L; Zhang Q; Meng Y; Hao J; Xie B; Gan H; Li D; Dong K; Zhang Z
    J Chromatogr A; 2018 Sep; 1569():160-167. PubMed ID: 30055911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.
    Sommers CD; Ye H; Kolinski RE; Nasr M; Buhse LF; Al-Hakim A; Keire DA
    Anal Bioanal Chem; 2011 Nov; 401(8):2445-54. PubMed ID: 21901459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies.
    Bisio A; Urso E; Guerrini M; de Wit P; Torri G; Naggi A
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28672818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
    Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
    J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway.
    Ghonim MA; Wang J; Ibba SV; Luu HH; Pyakurel K; Benslimane I; Mousa S; Boulares AH
    J Transl Med; 2018 Sep; 16(1):243. PubMed ID: 30172259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models.
    Alyahya R; Sudha T; Racz M; Stain SC; Mousa SA
    Int J Oncol; 2015 Mar; 46(3):1225-31. PubMed ID: 25530018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity.
    Lopalco L; Ciccomascolo F; Lanza P; Zoppetti G; Caramazza I; Leoni F; Beretta A; Siccardi AG
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):787-93. PubMed ID: 7986584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of pro- and anti-proliferative oligosaccharides of heparins.
    Lean QY; Patel RP; Stewart N; Sohal SS; Gueven N
    Integr Biol (Camb); 2014 Jan; 6(1):90-9. PubMed ID: 24310794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combinatorial one-pot chemoenzymatic synthesis of heparin.
    Bhaskar U; Li G; Fu L; Onishi A; Suflita M; Dordick JS; Linhardt RJ
    Carbohydr Polym; 2015 May; 122():399-407. PubMed ID: 25817684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification of ulvans via periodate-chlorite oxidation: Chemical characterization and anticoagulant activity.
    de Carvalho MM; de Freitas RA; Ducatti DRB; Ferreira LG; Gonçalves AG; Colodi FG; Mazepa E; Aranha EM; Noseda MD; Duarte MER
    Carbohydr Polym; 2018 Oct; 197():631-640. PubMed ID: 30007656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives.
    Schlesinger M; Schmitz P; Zeisig R; Naggi A; Torri G; Casu B; Bendas G
    Thromb Res; 2012 May; 129(5):603-10. PubMed ID: 22099706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parent heparin and daughter LMW heparin correlation analysis using LC-MS and NMR.
    Liu X; St Ange K; Wang X; Lin L; Zhang F; Chi L; Linhardt RJ
    Anal Chim Acta; 2017 Apr; 961():91-99. PubMed ID: 28224913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin.
    Zhang B; Shi D; Li M; Shi F; Chi L
    Carbohydr Polym; 2023 Feb; 301(Pt A):120303. PubMed ID: 36436866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM; Mackie IM
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure of the antithrombin-binding site in heparin.
    Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural features and bleeding activity of commercial low molecular weight heparins: neutralization by ATP and protamine.
    Dietrich CP; Shinjo SK; Moraes FA; Castro RA; Mendes A; Gouvea TC; Nader HB
    Semin Thromb Hemost; 1999; 25 Suppl 3():43-50. PubMed ID: 10549715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of hydrophilic interaction chromatography with quadruple time-of-flight mass spectrometry for heparin and low molecular weight heparin disaccharide analysis.
    Ouyang Y; Wu C; Sun X; Liu J; Linhardt RJ; Zhang Z
    Rapid Commun Mass Spectrom; 2016 Jan; 30(2):277-84. PubMed ID: 26689158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems.
    Longstaff C; Hogwood J; Gray E; Komorowicz E; Varjú I; Varga Z; Kolev K
    Thromb Haemost; 2016 Mar; 115(3):591-9. PubMed ID: 26632486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.
    Edens RE; al-Hakim A; Weiler JM; Rethwisch DG; Fareed J; Linhardt RJ
    J Pharm Sci; 1992 Aug; 81(8):823-7. PubMed ID: 1328601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases.
    Ofosu FA
    Thromb Res; 2008; 123(1):5-7. PubMed ID: 18284938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.